Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies. [electronic resource]
Producer: 20160701Description: 10-20 p. digitalISSN:- 1423-0232
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cisplatin -- administration & dosage
- Docetaxel
- Drug Administration Schedule
- Febrile Neutropenia -- chemically induced
- Female
- Fluorouracil -- administration & dosage
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Hypertension -- chemically induced
- Infusions, Intravenous
- Male
- Middle Aged
- Molecular Targeted Therapy
- Neoplasms -- drug therapy
- Receptors, Vascular Endothelial Growth Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Taxoids -- administration & dosage
- Thrombocytopenia -- chemically induced
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.